MSE
GILD icon

MUFG Securities EMEA’s Gilead Sciences GILD Stock Holding History

MUFG Securities EMEA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-300,000
Closed -$35.1M – 108
2015
Q2 		$35.1M Buy
+300,000
New +$32.8M 5.82% 3
2015
Q1 		– Sell
-200,000
Closed -$18.9M – 101
2014
Q4 		$18.9M Buy
200,000
+50,000
+33% +$5.17M 4.97% 5
2014
Q3 		$16M Buy
+150,000
New +$14.7M 2.38% 8

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MUFG Securities EMEA's GILD Position: Q2 2026 in Review

MUFG Securities EMEA increased its Gilead Sciences (GILD) stake by 13% in Q2 2026, buying an estimated $8.72M and bringing the position to 588,075 shares worth $74.3M. The position accounts for 0.78% of the portfolio, ranked #31.

MUFG Securities EMEA first reported a position in GILD in Q4 2013 and has held it in 45 quarters since. The position peaked at $85.5M in Q3 2021. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MUFG Securities EMEA held 588,075 shares of Gilead Sciences worth $74.3M as of Q2 2026.
  • MUFG Securities EMEA bought 66,213 Gilead Sciences shares in Q2 2026, an estimated $8.72M.
  • Gilead Sciences made up 0.78% of MUFG Securities EMEA's portfolio in Q2 2026, its #31 holding.
  • MUFG Securities EMEA first reported a position in Gilead Sciences in Q4 2013 and has held it in 45 quarters since.
  • MUFG Securities EMEA's Gilead Sciences position peaked at $85.5M in Q3 2021.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.